Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Complete remission vs classical healing in erosive GERD with pantoprazole
2006-000927-33Phase 4Completed
- Sponsor
- Nycomed
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pantoprazole in erosive esophagitis (EE), sponsored by Nycomed. Primary endpoint: Time to endoscopic relapse or discontinuation due to GERD symptoms. Started Oct 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on 2006-000927-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000927-33.